These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Erkanli L, Akova YA, Guney-Tefekli E, Tugal-Tutkun I. Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295 [Abstract] [Full Text] [Related]
7. Mycophenolate mofetil for ocular inflammation. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178 [Abstract] [Full Text] [Related]
9. Mycophenolate mofetil for the treatment of scleritis. Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873 [Abstract] [Full Text] [Related]
10. Posterior scleritis in children: clinical features and treatment. Cheung CM, Chee SP. Ophthalmology; 2012 Jan; 119(1):59-65. PubMed ID: 22137553 [Abstract] [Full Text] [Related]
11. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases. Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group. Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346 [Abstract] [Full Text] [Related]
12. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease. Suelves AM, Arcinue CA, González-Martín JM, Kruh JN, Foster CS. Ophthalmology; 2013 Jun; 120(6):1201-9. PubMed ID: 23601800 [Abstract] [Full Text] [Related]
13. Scleritis therapy. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381 [Abstract] [Full Text] [Related]
14. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza MT, Foster CS. Ophthalmology; 2012 Jul; 119(7):1460-4. PubMed ID: 22463821 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil therapy for inflammatory eye disease. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096 [Abstract] [Full Text] [Related]
16. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE. Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209 [Abstract] [Full Text] [Related]
17. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Kiss S, Ahmed M, Letko E, Foster CS. Ophthalmology; 2005 Jun; 112(6):1066-71. PubMed ID: 15936442 [Abstract] [Full Text] [Related]
18. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis. Jachens AW, Chu DS. Am J Ophthalmol; 2008 Mar; 145(3):487-492. PubMed ID: 18282493 [Abstract] [Full Text] [Related]
19. Episcleritis and scleritis: clinical features and treatment results. Jabs DA, Mudun A, Dunn JP, Marsh MJ. Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419 [Abstract] [Full Text] [Related]
20. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Galor A, Perez VL, Hammel JP, Lowder CY. Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615 [Abstract] [Full Text] [Related] Page: [Next] [New Search]